• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Appearance of a novel measles G3 strain in multiple European countries within a two month period, 2010

Giuseppe

Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]


Eurosurveillance, Volume 16, Issue 17, 28 April 2011

Rapid communications
Appearance of a novel measles G3 strain in multiple European countries within a two month period, 2010


K E Brown ()<SUP>1</SUP>, M N Mulders<SUP>2</SUP>, F Freymuth<SUP>3</SUP>, S Santibanez<SUP>4</SUP>, M M Mosquera<SUP>5</SUP>, S Cordey<SUP>6</SUP>, J Beirnes<SUP>7</SUP>, S Shulga<SUP>8</SUP>, R Myers<SUP>1</SUP>, D Featherstone<SUP>9</SUP>
  1. Virus Reference Department, World Health Organization Global Specialised Laboratory for Measles and Rubella, Health Protection Agency - Colindale, London, United Kingdom
  2. World Health Organization Regional Office for Europe, Copenhagen, Denmark
  3. Centre National de R?f?rence de la Rougeole et des Paramyxoviridae Respiratoires (National Reference Centre for measles and respiratory Paramyxoviridae), Laboratoire de virologie humaine et mol?culaire (Laboratory of human and molecular virology), Centre Hospitalier Universitaire de Caen, France
  4. National Reference Centre Measles, Mumps, Rubella, Regional Reference Laboratory WHO EURO, Robert Koch Institute, Berlin, Germany
  5. Centro Nacional de Microbiolog?a (National Microbiology Centre), Instituto de Salud Carlos III, Madrid, Spain
  6. Swiss National Reference Centre for Emerging Viral Diseases, Division of Infectious Diseases, University of Geneva Hospitals, Geneva, Switzerland
  7. Viral Exanthemata National Microbiology Laboratory, Winnipeg, Canada
  8. World Health Organization Regional Reference Laboratory, European Region, Moscow, Russian Federation
  9. Expanded Programme on Immunization, Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
<HR>
Citation style for this article: Brown KE, Mulders MN, Freymuth F, Santibanez S, Mosquera MM, Cordey S, Beirnes J, Shulga S, Myers R, Featherstone D. Appearance of a novel measles G3 strain in multiple European countries within a two month period, 2010. Euro Surveill. 2011;16(17):pii=19852. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19852
Date of submission: 19 April 2011
<HR>During late 2010, a previously unrecognised strain of measles genotype G3 virus was identified in five different European countries by the World Health Organization Measles and Rubella Laboratory Network. Apart from one, none had a travel history to south-east Asia, the usual source of G3 viruses, although epidemiological links could be established between some of the cases. This case series illustrates the value of genotyping and sequencing in tracking measles infections, and identifying otherwise unrecognised chains of transmission.

- -----
 
Back
Top Bottom